Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Session 2 - Step-by-step development of specific classes of drugs, patient selection, relevant biomarkers and pharmacodynamics

Other agents: e.g. drug conjugates, hormonal agents, cell-based therapies,…

Date

24 Feb 2023

Session

Session 2 - Step-by-step development of specific classes of drugs, patient selection, relevant biomarkers and pharmacodynamics

Topics

Translational Research;  Cytotoxic Therapy;  Endocrine Therapy;  Cell-Based Therapy

Tumour Site

Presenters

A. Stathis, CH

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.